We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Is P&G Stock Worth Buying as Growth Slows and Valuation Stays Rich?
Read MoreHide Full Article
Key Takeaways
PG expects fiscal 2027 organic and all-in sales growth of 1-3%, with core EPS flat to up 3%.
PG trades at 20.3X forward earnings, above its sub-industry's 18.4X and Consumer Staples sector's 17.3X.
PG expects about $10B in dividends and roughly $5B in share repurchases in fiscal 2027.
The Procter & Gamble Company (PG - Free Report) , also referred to as P&G, enters fiscal 2027 with leading brands, high cash generation and a productivity program that continues to fund reinvestment. Those strengths matter, but the growth profile remains subdued.
The investment debate is therefore less about business quality than price. PG trades above key Zacks industry benchmarks even as earnings expectations point to low-single-digit progress.
P&G's Growth Outlook Remains Modest
P&G expects fiscal 2027 organic and all-in sales to rise 1-3%, while core earnings per share are projected to be flat to up 3% from $6.89. Management's midpoint for core EPS is $7.00.
The current Zacks Consensus Estimates call for 1.8% sales growth and 1.6% core EPS growth to $7.00. Colgate-Palmolive Company (CL - Free Report) reported 2.4% organic sales growth and 8% base-business EPS growth in second-quarter 2026.
Kimberly-Clark Corporation (KMB - Free Report) posted 1.2% organic sales growth for the first half of 2026. Those peer results also show how restrained top-line growth remains across major consumer staples companies.
Image Source: Zacks Investment Research
PG's Valuation Leaves Little Room for Error
PG trades at 20.3X forward 12-month earnings versus 18.4X for the Zacks sub-industry and 17.3X for the Zacks Consumer Staples sector. The stock remains below its five-year median of 23.4X but still carries a clear relative premium.
That premium looks demanding alongside expected sales and earnings growth near 2% or less. With growth modest, consistent execution on volume, pricing and productivity becomes increasingly important.
P&G Productivity Helps Offset Margin Pressure
Fiscal 2026 delivered about $2.8 billion of before-tax productivity improvement, equal to roughly 340 basis points. Those savings helped fund product, packaging and brand investment.
Even so, core gross margin fell 40 basis points and core operating margin declined 70 basis points. Fiscal 2027 also carries about $1 billion of after-tax pressure from raw materials, energy, transportation and related costs, much of it expected in the first half.
PG Innovation Supports Selective Growth
The upgraded Tide original liquid formula moved from declining sales to high-single-digit growth by the fiscal fourth quarter after P&G improved product performance without raising the price.
Tide evo is moving toward broader national expansion in fiscal 2027. SK-II has delivered double-digit organic sales growth for six consecutive quarters, showing that targeted innovation can still produce stronger growth in selected franchises.
Procter & Gamble Company (The) Price, Consensus and EPS Surprise
Fiscal 2026 operating cash flow reached $19.56 billion, while adjusted free cash flow was $15.84 billion. P&G returned more than $15 billion to shareholders through $10.2 billion of dividends and $5.0 billion of share repurchases.
For fiscal 2027, management expects about $10 billion of dividends and roughly $5 billion of repurchases. That return profile offers support while earnings growth remains restrained, though it does not remove valuation and margin risks.
PG's Scores Point to Near-Term Caution
Bottom line, P&G retains durable operating strengths, but fiscal 2027 growth looks modest relative to its valuation premium. Productivity, innovation and cash returns help the case, yet near-term execution risk remains.
PG currently carries a Zacks Rank #4 (Sell). Its Value Score of D, Momentum Score of D and VGM Score of D are weak, while its Growth Score of C is middling.
Zacks Style Scores are designed to complement the Zacks Rank over a similar 1-3 month horizon. The current combination supports a cautious near-term stance rather than a more aggressive entry at today's valuation.
View the Zacks #1 Rank List
Image: Bigstock
Is P&G Stock Worth Buying as Growth Slows and Valuation Stays Rich?
Key Takeaways
The Procter & Gamble Company (PG - Free Report) , also referred to as P&G, enters fiscal 2027 with leading brands, high cash generation and a productivity program that continues to fund reinvestment. Those strengths matter, but the growth profile remains subdued.
The investment debate is therefore less about business quality than price. PG trades above key Zacks industry benchmarks even as earnings expectations point to low-single-digit progress.
P&G's Growth Outlook Remains Modest
P&G expects fiscal 2027 organic and all-in sales to rise 1-3%, while core earnings per share are projected to be flat to up 3% from $6.89. Management's midpoint for core EPS is $7.00.
The current Zacks Consensus Estimates call for 1.8% sales growth and 1.6% core EPS growth to $7.00. Colgate-Palmolive Company (CL - Free Report) reported 2.4% organic sales growth and 8% base-business EPS growth in second-quarter 2026.
Kimberly-Clark Corporation (KMB - Free Report) posted 1.2% organic sales growth for the first half of 2026. Those peer results also show how restrained top-line growth remains across major consumer staples companies.
Image Source: Zacks Investment Research
PG's Valuation Leaves Little Room for Error
PG trades at 20.3X forward 12-month earnings versus 18.4X for the Zacks sub-industry and 17.3X for the Zacks Consumer Staples sector. The stock remains below its five-year median of 23.4X but still carries a clear relative premium.
That premium looks demanding alongside expected sales and earnings growth near 2% or less. With growth modest, consistent execution on volume, pricing and productivity becomes increasingly important.
P&G Productivity Helps Offset Margin Pressure
Fiscal 2026 delivered about $2.8 billion of before-tax productivity improvement, equal to roughly 340 basis points. Those savings helped fund product, packaging and brand investment.
Even so, core gross margin fell 40 basis points and core operating margin declined 70 basis points. Fiscal 2027 also carries about $1 billion of after-tax pressure from raw materials, energy, transportation and related costs, much of it expected in the first half.
PG Innovation Supports Selective Growth
The upgraded Tide original liquid formula moved from declining sales to high-single-digit growth by the fiscal fourth quarter after P&G improved product performance without raising the price.
Tide evo is moving toward broader national expansion in fiscal 2027. SK-II has delivered double-digit organic sales growth for six consecutive quarters, showing that targeted innovation can still produce stronger growth in selected franchises.
Procter & Gamble Company (The) Price, Consensus and EPS Surprise
Procter & Gamble Company (The) price-consensus-eps-surprise-chart | Procter & Gamble Company (The) Quote
P&G Cash Returns Add Shareholder Support
Fiscal 2026 operating cash flow reached $19.56 billion, while adjusted free cash flow was $15.84 billion. P&G returned more than $15 billion to shareholders through $10.2 billion of dividends and $5.0 billion of share repurchases.
For fiscal 2027, management expects about $10 billion of dividends and roughly $5 billion of repurchases. That return profile offers support while earnings growth remains restrained, though it does not remove valuation and margin risks.
PG's Scores Point to Near-Term Caution
Bottom line, P&G retains durable operating strengths, but fiscal 2027 growth looks modest relative to its valuation premium. Productivity, innovation and cash returns help the case, yet near-term execution risk remains.
PG currently carries a Zacks Rank #4 (Sell). Its Value Score of D, Momentum Score of D and VGM Score of D are weak, while its Growth Score of C is middling.
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Zacks Style Scores are designed to complement the Zacks Rank over a similar 1-3 month horizon. The current combination supports a cautious near-term stance rather than a more aggressive entry at today's valuation.